MAGI2 and head and neck carcinoma: Additionally, analysis using online software—DiseaseMeth 2.0 [27] revealed that MAGI2-AS3 promoter was hypermethylated in several cancers such as colon adenocarcinoma, head and neck carcinoma, uterine endometrial carcinoma, and rectal and anal adenocarcinoma.